Kane Biotech Announces Proposed Amendments to its Credit Facility and Changes to its Board of Directors
March 01, 2023 08:53 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, March 01, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the...
Kane Biotech Announces Extension of Term of Credit Facility
February 06, 2023 07:31 ET
|
Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
Kane Biotech Announces First Distribution Agreement for its coactiv+™ Antimicrobial Hydrogel
January 04, 2023 07:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has recently signed a distribution agreement...
Kane Biotech Announces Loan Transaction
December 29, 2022 17:34 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has reached an agreement to obtain loans...
Kane Biotech Announces Third Quarter 2022 Financial Results
November 24, 2022 16:10 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2022 financial results. ...
Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 – Conference Call to Follow
November 17, 2022 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Announces 510(k) Submission for its coactiv+™ Antimicrobial Hydrogel
November 03, 2022 07:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces that it has recently submitted a 510(k) premarket...
Kane Biotech to Present at Symposium on Advanced Wound Care Fall Forum
October 13, 2022 16:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that the Company will be presenting at the Symposium...
Kane Biotech Receives an Additional $425K USD of Funding for its DispersinB® Hydrogel from the United States Department of Defense
October 04, 2022 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has received an additional $425,000 USD of...
Kane Biotech Announces Second Quarter 2022 Financial Results
August 25, 2022 16:12 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its second quarter 2022 financial results. Second...